Serum Enzymes 101 — Introduction & Kinetics

Clinical Chemistry — ASCP Exam Prep Serum Enzymes 101 — Introduction & Kinetics

Master enzyme kinetics, Michaelis-Menten equation, factors affecting enzyme activity, and methods for measuring enzyme activity for ASCP clinical chemistry MCQs.

📘 Chapter 2 — Enzymes
ASCP Board Exam — Lab-Focused Study Guide
Methods • Clinical Interpretation • Pre-analytical Variables • Practice Questions

What Does ASCP Actually Test From This Chapter?

Before studying, know what matters. The ASCP MLS exam is NOT a biochemistry exam. It tests whether you understand clinical relevance and can work in the lab.

Priority	Topic
HIGH	Enzyme assay methods — principle, coupled reactions, sources of error
HIGH	CK isoenzymes — which one = AMI, which one = muscle disease
HIGH	LD isoenzymes — flipped pattern, storage rule, when it matters
HIGH	Liver enzymes — AST vs ALT specificity, ALP isoenzyme differentiation
HIGH	Pancreatic enzymes — Lipase vs Amylase (which is better and why)
HIGH	Pre-analytical errors — hemolysis effects on EACH enzyme
HIGH	Patient scenarios — given labs + symptoms, identify the organ/disease
MEDIUM	Enzyme kinetics — Km, Vmax, zero-order kinetics, inhibitor types
MEDIUM	Mechanism of enzyme release — WHY levels rise in tissue injury
MEDIUM	Diagnostic window concept — onset, peak, duration for each marker
LOW	Deep IUB classification details, exact amino acid sequences, rare enzyme deficiencies

Focus your time on: HOW we measure enzymes, WHAT the results mean clinically, and WHEN one enzyme is more useful than another. The mechanism of WHY levels rise is medium priority but explains patterns you need to recognize.

1. Why Enzyme Levels Rise — The Mechanism

1.1 The Cell Injury Cascade — How Enzymes Escape

This is the ‘why’ behind enzyme testing. Understanding this mechanism will help you answer questions about timing, patterns, and interpretation of enzyme results.

Step	What Happens — The Mechanism
Step 1: Normal state	Enzymes are locked INSIDE cells at concentrations 1,000–50,000× higher than serum. The cell membrane acts as a barrier.
Step 2: Injury begins	Any injury (ischemia, toxin, virus, trauma) reduces ATP production in the cell. Without ATP, the membrane pump (Na⁺/K⁺-ATPase) fails.
Step 3: Cell swells	Na⁺ and water flood into the cell. The cell swells (edema). This is still REVERSIBLE at this stage.
Step 4: Calcium enters	Ca²⁺ enters the injured cell → activates intracellular enzymes (phospholipases, proteases) → attacks the membrane from inside.
Step 5: Membrane leaks	Small cytoplasmic enzymes leak out FIRST (they diffuse through the damaged membrane). This is the first detectable sign in blood.
Step 6: If irreversible	Mitochondrial membranes also rupture → mitochondrial enzymes released (e.g., AST-mitochondrial form). This indicates NECROSIS.
Step 7: Enzyme in blood	Leaked enzyme enters interstitial fluid → lymphatics → bloodstream. Some tissues (liver) drain directly into capillaries. Muscle drains via lymphatics (SLOWER to appear).

⚠️ EXAM TIP: Cytoplasmic enzymes appear in blood FIRST = early/reversible injury marker. Mitochondrial enzymes appear LATER = necrosis/irreversible injury. Example: Mitochondrial AST elevated = severe cell death, not just mild damage.

1.2 Why Different Enzymes Rise at Different Times

Factor	How It Affects the Timing in Blood
Molecular weight	Smaller enzymes diffuse out of cells faster. Amylase (55 kDa) appears quickly. Large complexes appear slowly.
Intracellular location	Cytoplasmic enzymes leak first. Membrane-bound enzymes require membrane breakdown. Mitochondrial enzymes require two membranes to rupture.
Tissue vascularity	Liver is highly vascular → enzymes reach blood directly and FAST. Skeletal muscle has less permeable capillaries → enzymes travel via LYMPHATICS = SLOWER.
Tissue mass	A large organ (liver = 1000g, high enzyme concentration) releases massive amounts. Small organ (prostate = 20g) releases less.
Rate of enzyme production	Some enzymes are INDUCED by the injury itself (e.g., ALP and GGT are synthesized MORE by liver cells in cholestasis — not just leaked).
Half-life in blood	Enzymes with short half-lives disappear faster after injury. Long half-life = stays elevated longer = better for late presentations.

Two mechanisms raise serum enzymes: (1) LEAKAGE from damaged/dying cells = most common. (2) INCREASED SYNTHESIS = ALP in bone growth and cholestasis, GGT after drug induction. Understanding which mechanism applies changes how you interpret the result.

2. The Diagnostic Window — A Critical Framework

2.1 What Is a Diagnostic Window?

The diagnostic window is the time period after an injury during which a marker is elevated in the blood and therefore detectable. This concept explains WHEN to order which test and why a result might be normal even after a real injury.

Component	Definition & Clinical Importance
Onset (rise)	How quickly the marker appears after injury. Early markers = short onset = useful for ACUTE diagnosis. E.g., CK-MB rises in 4–8 hours after AMI.
Peak	When the marker reaches its highest concentration. Important for assessing injury severity and confirming the diagnosis.
Duration / Return to normal	How long the marker stays elevated. LONG duration = useful if patient presents LATE. SHORT duration = useful only for EARLY diagnosis.
Early indicator	Marker with short onset + short duration. Detects injury early but disappears quickly. Example: CK-MB in AMI (4-8h to 48-72h).
Late indicator	Marker with long onset but very long duration. Useful for LATE presentation patients. Example: LD in AMI (12-24h onset, stays elevated 10 DAYS).
Why it matters clinically	A patient presenting 5 days after chest pain will have NORMAL CK-MB but still ELEVATED LD with a flipped pattern → LD caught it, CK-MB missed it.

2.2 Diagnostic Windows for Key Enzymes in AMI

Marker	Onset (h)	Peak (h)	Returns Normal	Best Use
Troponin I/T	3–6	12–24	5–14 DAYS	GOLD STANDARD — most sensitive + specific
CK-MB	4–8	12–24	48–72 h	Confirms AMI + estimates infarct size. Good for reinfarction.
Total CK	4–8	18–30	3–4 days	Sensitive but NOT specific — elevated in any muscle damage
AST	6–8	24 h	5 days	Historical — not recommended for AMI anymore
LD (total)	12–24	48–72 h	10 DAYS	Late presentations only. Use LD-1 > LD-2 pattern.

⚠️ EXAM TIP: Classic scenario: Patient arrives 4 days after chest pain. CK-MB is normal. What do you check next? → LD isoenzymes. LD stays elevated for 10 days and LD-1 > LD-2 (flipped pattern) confirms the old MI that CK-MB already missed.

3. Factors That Determine Serum Enzyme Levels

3.1 The Four-Factor Model

The level of an enzyme in blood at any moment is NOT just about how much leaked out. It is determined by FOUR factors acting simultaneously. This model explains why the same injury can produce different enzyme patterns in different patients.

Factor	Explanation — What It Controls
1. Rate of release from cells	How fast enzyme is escaping from damaged tissue. Determined by: severity of injury, size of affected area, tissue vascularity (liver is faster than muscle).
2. Tissue concentration gradient	Enzymes inside cells are 1,000–50,000× more concentrated than in blood. Even minor damage releases detectable amounts because the gradient is so steep. Only 1 in 750 liver cells needs to be damaged to raise ALT detectably.
3. Rate of clearance from blood	Enzymes are removed from blood primarily by the reticuloendothelial system (RES) — bone marrow, spleen, liver Kupffer cells — via receptor-mediated endocytosis. NOT by urinary excretion (most enzymes are too large for glomerular filtration). Exception: Amylase (small, 55 kDa) — only enzyme normally filtered by kidney and found in urine.
4. Half-life in plasma	Each enzyme has a characteristic half-life (range: a few hours to several days). Short half-life = disappears quickly after injury. Long half-life = stays elevated long after. This determines the diagnostic window.

3.2 Enzyme Half-Lives — Key Numbers for ASCP

Enzyme / Isoform	Half-Life (approx)
Lipase (pancreatic)	Short (~12-24 h)
CK-MB	~10-12 hours
CK-MM	~20 hours
ALT	~24 hours (serum)
Cytoplasmic AST	~12 hours
Mitochondrial AST	~80 hours
Bone ALP	~40-70 hours
GGT	~72-100 hours
LD-1 (cardiac)	~113 hours (~5 days)
Hepatic ALP	~140-170 hours
Amylase (serum)	Short (~2 hours)

⚠️ EXAM TIP — Clearance route is key: Most enzymes are cleared by the reticuloendothelial system (liver Kupffer cells, spleen, bone marrow). This is why liver disease can prolong the half-life of some enzymes — when parenchymal mass is reduced, clearance slows and enzyme levels stay high longer.

3.3 Biological & Pre-analytical Variables

Variable	Effect — What ASCP Wants You to Know
Sex	Males have higher CK (more muscle mass). Males have higher GGT. Females have lower ALP (less bone ALP after puberty until menopause).
Age	Children have high ALP (bone growth). Neonates have high CK (birth trauma to muscle). LD reference intervals higher in children.
Race	Black individuals have higher CK than non-Black (~20-30% higher). Important to avoid over-diagnosing muscle disease.
Physical exercise	CK-MM elevated up to 10× ULN within 24 hours of strenuous unaccustomed exercise. Can persist 48 hours. Confounds cardiac CK-MB interpretation.
Intramuscular injection	CK elevated <5× ULN. Resolves within 48 hours. Important to document IM injections before drawing CK.
Statins	Cause dose-dependent CK elevation in some patients. Severe = statin-induced myopathy or rhabdomyolysis. Check CK if muscle pain + statin use.
Alcohol	Elevates GGT significantly (2-3× ULN or more). Even short-term heavy drinking. GGT normalizes ~2-3 weeks after stopping.
Pregnancy	ALP elevated up to 3× ULN in third trimester (placental isoenzyme). GGT is NORMAL in pregnancy — key differentiator.

4. Enzyme Kinetics — What You Need for ASCP

4.1 The Two Kinetic States — CRITICAL Distinction

This is the most-tested kinetics concept. All clinical enzyme ACTIVITY assays must run under zero-order kinetics. Understanding why is the key to understanding sources of error.

Kinetic State	Condition
First-order kinetics	LOW substrate concentration (substrate limiting). Reaction rate depends on substrate concentration.
Zero-order kinetics	HIGH substrate concentration (enzyme saturated). Reaction rate depends ONLY on enzyme concentration. Required for activity assays.

In zero-order kinetics, the reaction rate tells us ONLY about enzyme concentration — not about substrate. This is why enzyme activity assays must: (1) keep substrate in large excess, (2) measure during the LINEAR phase before substrate runs out, (3) use ≤20% substrate conversion maximum.

4.2 Michaelis-Menten — What the Numbers Mean

Term	Simple Definition
Km (Michaelis constant)	The substrate concentration at which the enzyme works at HALF its maximum speed. Lower Km = enzyme works efficiently even at low substrate = higher affinity.
Vmax (maximum velocity)	The fastest possible reaction rate when enzyme is completely saturated with substrate.
Lineweaver-Burk plot	A double-reciprocal graph (1/V vs 1/[S]) that converts the Michaelis-Menten curve into a straight line. X-intercept = -1/Km. Y-intercept = 1/Vmax.

4.3 Enzyme Inhibitors — The MCQ Killer Table

Know these patterns cold — inhibitor questions are classic ASCP exam traps. The key is: does the inhibitor affect Km, Vmax, or both?

Inhibitor	Where It Binds	Vmax	Km	Substrate overcome?
Competitive	Active site — competes directly with substrate	UNCHANGED	APPEARS INCREASED	YES — reversible with excess substrate
Noncompetitive	Allosteric site — binds enzyme OR enzyme-substrate complex	DECREASED	UNCHANGED	NO — adding substrate does NOT help
Uncompetitive	Binds ONLY the enzyme-substrate (ES) complex	DECREASED	APPEARS DECREASED	NO — adding substrate INCREASES inhibition

⚠️ EXAM TIP — Inhibitor Memory Trick:
COMPETITIVE: ‘Fighting for the same spot’ — adding more substrate WINS. Vmax SAME, Km APPEARS higher.
NONCOMPETITIVE: ‘Bends the enzyme out of shape’ — substrate still binds but product forms slowly. Vmax LOWER, Km SAME.
UNCOMPETITIVE: ‘Only grabs the working complex’ — more substrate = more ES = more inhibited. BOTH Vmax and Km APPEAR lower.

4.4 IUB Enzyme Classification

EC Class	Type
Class 1: Oxidoreductases	Catalyze oxidation-reduction (transfer electrons)
Class 2: Transferases	Transfer a chemical group (amino, phosphate, etc.)
Class 3: Hydrolases	Split bonds with water (hydrolysis)
Class 4: Lyases	Remove groups WITHOUT hydrolysis, leaving double bonds
Class 5: Isomerases	Convert between isomers
Class 6: Ligases	Join two molecules using ATP energy

Most clinically measured enzymes are Class 3 Hydrolases (ALP, ACP, AMY, LPS, CHE) or Class 2 Transferases (CK, AST, ALT, GGT). The class number is rarely directly tested — but knowing that ALP is a hydrolase explains why it needs an alkaline pH to cleave phosphate esters.

5. Measuring Enzymes in the Laboratory

5.1 Why We Measure Activity, Not Mass

Enzymes are present in blood at very low concentrations — too small to measure directly by most methods. Instead, we measure CATALYTIC ACTIVITY — what the enzyme DOES rather than what it IS.

Concept	Explanation
Catalytic activity assay	Measures the RATE of substrate → product conversion. Rate is proportional to enzyme concentration when substrate is in excess (zero-order kinetics).
Mass (immunoassay) method	Measures actual enzyme PROTEIN concentration using antibodies. Used for CK-MB. Can detect INACTIVE enzyme. Higher sensitivity.
International Unit (IU)	Amount of enzyme that converts 1 µmol of substrate per MINUTE under specified conditions. Reported as U/L or IU/L.
Katal	SI unit: moles converted per SECOND. 1 IU = 17 nkat. Rarely used in clinical practice.
Why measure at 37°C	Temperature must be strictly controlled (±0.1°C) because enzyme activity doubles with every 10°C rise. Reference ranges are method- and temperature-specific.
NADH at 340 nm	Most enzyme assays are coupled to NAD⁺/NADH conversion. NADH absorbs at 340 nm, NAD⁺ does NOT. Absorbance change at 340 nm = direct measure of reaction progress.

5.2 Assay Methods — Fixed-Time vs. Continuous Monitoring

Method	Principle
Fixed-time (endpoint)	Reaction runs for set time, then stopped. Single measurement at end.
Continuous monitoring (kinetic)	Multiple absorbance readings during reaction (every 30-60 sec). Plots the reaction curve.
Coupled enzyme assay	Enzyme of interest is not directly measured. Its product is substrate for an INDICATOR enzyme that produces a measurable signal (usually NADH change at 340 nm).

⚠️ EXAM TIP: Most common cause of falsely LOW enzyme activity = substrate depletion. FIX: Dilute the patient sample (not the reagent). Multiply result by dilution factor. This ONLY works with continuous monitoring.

🧰 PRE-ANALYTICAL KEY RULE: LD specimens MUST be stored at ROOM TEMPERATURE (25°C) — NOT refrigerated and NOT frozen. Cold destroys LD-4 and LD-5 specifically, causing falsely low total LD and altered isoenzyme patterns. This is the most-tested pre-analytical fact for enzymes.

6. Creatine Kinase (CK) — Muscle & Cardiac Marker

Feature	Details
What it does	Catalyzes: Creatine + ATP ⇌ Creatine Phosphate + ADP. Regenerates ATP in muscle cells during contraction.
Molecular weight	~82 kDa dimeric enzyme (two 40 kDa subunits: B and M)
Richest tissues	Skeletal muscle (50,000× serum) > Heart (10,000×) > Brain/smooth muscle (5,000×)
Liver & RBCs	ESSENTIALLY DEVOID of CK. CK elevation NEVER indicates liver disease. Hemolysis does NOT directly raise CK.
Hemolysis special case	RBCs have NO CK but have high adenylate kinase (AK). AK reacts with ADP in the assay reagent → falsely elevated CK. Significant with Hgb >320 mg/L.

6.1 CK Isoenzymes — The Core Table

Isoenzyme	Subunits	Electrophoresis	Main Tissue	Clinical Significance
CK-BB (CK-1)	BB	Fastest (most anodal)	Brain, smooth muscle	Rarely detected in normal serum. Short half-life (1-5h). Brain injury (stroke, seizure), some tumors.
CK-MB (CK-2)	MB	Intermediate	Heart (22%), skeletal muscle (1-3%)	>6% of total CK OR mass >5 µg/L = significant for myocardial injury. Best enzymatic AMI marker.
CK-MM (CK-3)	MM	Slowest (most cathodal)	Skeletal muscle (97%), heart (78%)	94-100% of normal serum CK. Elevated in ALL muscle disorders. HIGHEST in Duchenne MD (50-100× ULN).
CK-Mt (Mito)	Mitochondrial	Cathodal to CK-MM	Heart, muscle, liver mitochondria	NOT in normal serum. Requires EXTENSIVE tissue destruction. POOR PROGNOSIS indicator.

6.2 Macro-CK — The Trap Question

Type	What It Is
Macro-CK Type 1	CK-BB (or other CK) bound to IgG or IgA immunoglobulin. Forms a large complex.
Macro-CK Type 2	Oligomeric mitochondrial CK (CK-Mt). Multiple units aggregated.

⚠️ EXAM TIP: A patient has unexplained elevated CK-MB by immunoinhibition method, but normal Troponin and no clinical AMI evidence. Think Macro-CK Type 1. Gold standard detection: electrophoresis shows atypical band between MM and MB.

6.3 CK Assay Method

Feature	Details
Reaction used	REVERSE reaction (CrP + ADP → Cr + ATP). Runs 2-6× faster than forward reaction.
Coupled system	CK reaction → ATP → Hexokinase → Glucose-6-phosphate → G6PD → NADPH. Measured at 340 nm.
Activators added	N-acetylcysteine (reactivates CK sulfhydryl). EDTA (binds Ca²⁺). Ap5A (inhibits AK interference).
Preferred specimen	Serum or heparin plasma. EDTA, citrate, oxalate = chelate Mg²⁺ = INHIBIT assay.
Light sensitivity	CK is inactivated by light exposure. Store specimens in dark.
Stability	<8h at RT. 48h at 4°C. 1 month at −20°C.
Reference ranges	Males: 46–171 U/L. Females: 34–145 U/L. Higher in males and Black individuals.

7. Lactate Dehydrogenase (LD) — The Late-Stage Marker

Feature	Details
What it does	L-Lactate + NAD⁺ ⇌ Pyruvate + NADH + H⁺. Reversible reaction. Measured at 340 nm (NADH change).
Structure	Tetramer (134 kDa). Four polypeptide chains of two types: H (heart) and M (muscle). Five isoenzymes.
Distribution	Found in ALL tissues (cytoplasm only). High in heart, liver, skeletal muscle, RBCs, kidney.
Normal serum pattern	LD-2 > LD-1 > LD-3 > LD-4 > LD-5. LD-2 is normally the highest fraction.
Preferred specimen	SERUM (NOT plasma — platelets contain high LD, contaminate plasma). SEPARATE FROM CLOT ASAP.
Storage — CRITICAL	Room temperature (25°C) ONLY. Do NOT refrigerate or freeze — cold destroys LD-4 and LD-5.

7.1 LD Isoenzymes — Complete Reference

Isoenzyme	Subunits	Main Tissue	% Serum	Significance
LD-1	HHHH	Heart, RBCs, Kidneys	14–26%	AMI: LD-1 > LD-2 = FLIPPED. Hemolytic/megaloblastic anemia, renal infarction.
LD-2	HHHM	Heart, RBCs	29–39%	Normally HIGHEST. If LD-1 > LD-2 = pathologic.
LD-3	HHMM	Lung, Lymph, Spleen, Pancreas	20–26%	Pulmonary embolism, lymphoma, carcinoma, acute pancreatitis.
LD-4	HMMM	Liver, Skeletal muscle	8–16%	Hepatic injury, skeletal muscle damage. Most labile — destroyed first by cold.
LD-5	MMMM	Liver, Skeletal muscle	6–16%	Liver disease (hepatitis, cirrhosis). MOST LABILE — destroyed by cold.

⚠️ EXAM TIP — The Flipped Pattern: Normal = LD-2 > LD-1. Flipped = LD-1 > LD-2. Flipped pattern strongly suggests: (1) AMI, (2) Intravascular hemolysis, (3) Hemolyzed SPECIMEN (in vitro hemolysis also flips pattern — pre-analytical error, NOT true disease!). Always distinguish in vivo from in vitro hemolysis.

7.2 LD Clinical Uses

Clinical Use	LD Pattern
Late AMI presentation (>48h)	Total LD elevated + LD-1 > LD-2 (flipped)
Megaloblastic anemia (B12/folate)	HIGHEST LD levels — up to 50× ULN. LD-1 and LD-2 predominant.
Hemolytic anemia	LD-1 and LD-2 elevated (RBC origin). LD-5 normal.
Leukemia / Lymphoma	Total LD elevated. Used for monitoring.
Liver disease	LD-4 and LD-5 elevated
Pleural effusion	LD measured in pleural fluid + serum simultaneously

In current clinical practice, LD is primarily useful in HEMATOLOGY and ONCOLOGY (megaloblastic anemia, lymphoma, germ cell tumors). It is no longer recommended as a primary cardiac marker (Troponin replaced it). But it’s still important for the ASCP exam because of the flipped pattern and the storage rules.

8. Aminotransferases — AST & ALT (Liver & Beyond)

8.1 AST — Aspartate Aminotransferase

Feature	Details
Reaction	L-Aspartate + α-ketoglutarate ⇌ Oxaloacetate + Glutamate. Coenzyme: Pyridoxal-5′-phosphate (P-5′-P / Vitamin B6).
Two forms (isoenzymes)	Cytoplasmic (c-AST): Released with MILD/REVERSIBLE injury. Mitochondrial (m-AST): Released only with SEVERE NECROSIS.
Tissue distribution	Heart (7800×serum) > Liver (7100×) > Skeletal muscle (5000×) > Kidney > RBCs. NOT liver-specific.
NOT useful for AMI	Although AST is high in heart, it is also high in liver and muscle. Troponin and CK-MB are used instead.
Hemolysis	Avoid — RBCs contain significant AST. Even mild hemolysis causes FALSE ELEVATION.
Reference range	Adults: ≤35 U/L (IFCC). Children younger than 3: 2× adult values.

8.2 ALT — Alanine Aminotransferase

Feature	Details
Reaction	L-Alanine + α-ketoglutarate ⇌ Pyruvate + Glutamate. Coenzyme: Pyridoxal-5′-phosphate. Exclusively CYTOPLASMIC.
Tissue distribution	LIVER (2850×) > Kidney (1200×) > Heart (450×) > Skeletal muscle (300×). Liver concentration much higher than for AST.
Clinical significance	MORE LIVER-SPECIFIC than AST. Rarely seen outside parenchymal liver disease. Persists LONGER than AST.
Hemolysis	Relatively UNAFFECTED by hemolysis — better choice when hemolysis is present.
Reference range	Males: ≤60 U/L. Females: ≤42 U/L (IFCC). Clear sex difference.
AMI	ALT usually NORMAL in uncomplicated AMI. If elevated = secondary liver damage from reduced cardiac output.

8.3 AST:ALT Ratio (AAR) — Pattern Recognition

AST:ALT Ratio	Pattern
ALT > AST (ratio <1)	Most liver disease (viral hepatitis, NAFLD, toxic hepatitis)
AST:ALT >2	ALCOHOLIC HEPATITIS until proven otherwise
AST:ALT >1 (chronic liver disease)	Advanced fibrosis/cirrhosis (~90% PPV)
Both markedly elevated (>10× ULN)	Massive parallel rise — hepatic ischemia, severe acute hepatitis

⚠️ EXAM TIP — AST:ALT Ratio Rules:
(1) AST:ALT >2 = ALCOHOLIC HEPATITIS until proven otherwise.
(2) AST:ALT >1 + chronic liver disease = advanced fibrosis/cirrhosis with ~90% PPV.
(3) ALT stays elevated LONGER than AST after hepatocellular injury — better for monitoring recovery.

Which enzyme is primary? For liver disease diagnosis and monitoring: START with ALT (more liver-specific). ADD AST as a reflex test if ALT >2× ULN to calculate the AAR for differential diagnosis and fibrosis assessment.

9. Alkaline Phosphatase (ALP) & GGT — Cholestatic Markers

9.1 Alkaline Phosphatase (ALP)

Feature	Details
What it does	Hydrolyzes phosphomonoesters at ALKALINE pH (optimum pH 9-10), releasing inorganic phosphate. Requires Mg²⁺ and Zn²⁺.
Mechanism of elevation	TWO mechanisms: (1) Leakage from damaged cells. (2) INDUCED SYNTHESIS — in cholestasis, bile salts stimulate hepatocytes to MAKE MORE ALP.
Key tissues	Liver (biliary canaliculi), Bone (osteoblasts), Intestine, Placenta, Kidney.
Specimen note	Use FASTING sample — fatty meal elevates intestinal ALP in blood group B or O secretors. Use serum or heparin.
Storage	Assay within 4 hours at room temp. Refrigerated sample: ALP activity INCREASES ~2%/day.

9.2 ALP Isoenzymes — Know All Four

Isoenzyme	Origin
Liver ALP	Liver (biliary pole of hepatocytes)
Bone ALP (BAP)	Osteoblasts
Intestinal ALP	Intestinal mucosa
Placental ALP	Placenta
Regan isoenzyme	Malignant tumors (lung, breast, ovary)
Nagao isoenzyme	Pancreatic/biliary adenocarcinomas

9.3 Differentiating ALP Sources

Situation	Best Approach
Is elevated ALP from liver or bone?	Check GGT: If GGT elevated → LIVER. If GGT normal → BONE (or pregnancy).
Heat stability test	Heat serum at 56°C for 10 min: Residual <20% = BONE. Residual >20% = LIVER. Placental ALP survives 65°C for 30 min.
Electrophoresis	Liver migrates fastest. Then bone, placental, intestinal. Bone and liver often overlap.
Phenylalanine inhibition	Inhibits INTESTINAL and PLACENTAL ALP. Does NOT differentiate liver from bone.
Immunoassay (bone-specific)	Direct measurement of bone ALP by antibody. Most specific.

⚠️ EXAM TIP — ALP Isoenzyme Rules: GGT NORMAL = bone or pregnancy (NOT liver). GGT ELEVATED = liver source confirmed. Placental ALP = HEAT STABLE (65°C, 30 min). Children have physiologically elevated ALP (bone growth) — NOT pathologic. Paget’s disease = HIGHEST ALP of any disease (10-25× ULN).

9.4 γ-Glutamyltransferase (GGT)

Feature	Details
What it does	Transfers γ-glutamyl group from glutathione to amino acids. Located on OUTER cell membrane (ectoenzyme).
Why it’s useful	Most sensitive enzyme for hepatobiliary disease. Best marker for ALCOHOL use. NOT elevated in bone disease or pregnancy.
Tissue distribution	Kidney (highest concentration) > Liver > Pancreas. Clinical serum GGT comes primarily from LIVER.
Alcohol effect	Rises 2-3× ULN. Returns to normal in 2-3 weeks after COMPLETE abstinence.
Drug induction	Warfarin, phenobarbital, phenytoin → GGT elevated up to 4× ULN WITHOUT liver damage.
GGT is NORMAL in	Bone disease. Normal pregnancy. Skeletal muscle disease.
Storage stability	Very stable: 1 week at 4°C, 1 year at −20°C. NOT affected by hemolysis.
Reference ranges	Males: 6-55 U/L. Females: 5-38 U/L. African ancestry: ~2× higher reference limits.

10. Pancreatic Enzymes — Amylase & Lipase

10.1 Amylase (AMY)

Feature	Details
What it does	Hydrolyzes α-1,4 glycosidic bonds in starch and glycogen → glucose, maltose, dextrins. Requires Ca²⁺ and Cl⁻. pH optimum: 6.9-7.0.
Molecular weight	50-55 kDa — SMALLEST serum enzyme. Only enzyme NORMALLY found in urine.
Main tissue sources	Salivary glands (S-type) and Pancreatic acinar cells (P-type).
Acute pancreatitis timing	Rise: 5-8 hours. Peak: 24 hours. Returns normal: 3-5 DAYS. Short window!
Degree of elevation	4-6× ULN typical. Magnitude does NOT correlate with severity.
Specificity problem	LOW specificity (20-60%). P-AMY (pancreatic isoenzyme) has HIGHER specificity (>90% when >3× ULN).

10.2 Non-Pancreatic Causes of Hyperamylasemia

Cause	AMY Pattern
Salivary gland disease (mumps, parotitis)	S-AMY elevated
Intra-abdominal disease (bowel obstruction)	P-AMY elevated (leaks through peritoneum)
Ectopic pregnancy (ruptured)	S-AMY from fallopian tube
Renal failure	Mixed — both types
Diabetic ketoacidosis (DKA)	Usually S-AMY
Macroamylasemia	S-AMY elevated in SERUM, urine AMY is LOW or ABSENT

10.3 Macroamylasemia — High-Yield

Feature	Details
What it is	Amylase forms complex with IgG/IgA → macrocomplex >200 kDa → too large for kidney filtration → retained in plasma.
Result pattern	Serum AMY persistently ELEVATED. Urine AMY LOW. Lipase NORMAL. Patient ASYMPTOMATIC.
Detection	Electrophoresis shows broad migrating band. PEG 6000 precipitation: residual AMY activity <30% = macroamylasemia confirmed.

⚠️ EXAM TIP — Amylase Interferences:
(1) MORPHINE/opiates: constrict sphincter of Oddi → falsely elevated AMY.
(2) HYPERTRIGLYCERIDEMIA: lipids inhibit amylase activity → falsely NORMAL AMY even in pancreatitis.
(3) EDTA/citrate: chelate Ca²⁺ → inhibit AMY. Use serum or heparin plasma only.

10.4 Lipase (LPS) — The Preferred Pancreatic Marker

Feature	Details
What it does	Hydrolyzes LONG-CHAIN TRIGLYCERIDES at 1 and 3 (α) positions → 2-monoglycerides + 2 fatty acids. Requires colipase + bile salts.
Why better than AMY	More specific for pancreatic damage. Stays elevated LONGER (7-14 days vs 3-5 days). NOT elevated in salivary gland disease.
Acute pancreatitis timing	Rise: 4-8 hours. Peak: 24 hours. Returns normal: 7-14 DAYS.
Diagnostic cutoff	LPS >3× ULN (no renal failure) = strong specific indicator of acute pancreatitis.
Hemolysis effect	Hemoglobin INHIBITS LPS → falsely LOW values. Avoid hemolysis — opposite of most other enzymes!
Reference range	<38 to <64 U/L (method-dependent, 37°C).

Lipase vs Amylase: Current guidelines recommend LIPASE as the FIRST-LINE and ONLY test for acute pancreatitis. Ordering BOTH amylase AND lipase is NOT recommended. Total AMY is now considered OBSOLETE for pancreatitis diagnosis.

11. ACP, G-6-PD, Cholinesterase & Macroenzymes

11.1 Acid Phosphatase (ACP)

Feature	Details
What it does	Hydrolyzes phosphomonoesters at ACID pH (~5.0). Mirror of ALP. Found in lysosomes.
Richest source	PROSTATE gland.
Tartrate-resistant ACP (TR-ACP)	Type 5b from OSTEOCLASTS. Marker of bone resorption. Elevated in Paget’s, bone metastases, Gaucher’s.
Prostatic ACP	INHIBITED by tartrate. REPLACED BY PSA. Still used in FORENSICS — vaginal ACP for seminal fluid (persists 4 days).
Stability	Extremely labile — decreases within 1-2 hours at room temperature! Must acidify specimen to pH <6.5 immediately.

11.2 Glucose-6-Phosphate Dehydrogenase (G-6-PD)

Feature	Details
What it does	Glucose-6-phosphate + NADP⁺ → 6-Phosphogluconate + NADPH. First step in pentose phosphate shunt.
Why NADPH matters	Regenerates REDUCED GLUTATHIONE → protects hemoglobin from oxidative damage. Without NADPH: oxidant drug → Heinz body → HEMOLYSIS.
G-6-PD deficiency	X-linked recessive. Most common in African Americans, Mediterranean, Southeast Asians.
Clinical presentation	DRUG-INDUCED HEMOLYTIC ANEMIA: primaquine, dapsone, nitrofurantoin, aspirin (high dose), sulfamethoxazole.
Testing timing trap	Test G-6-PD BETWEEN hemolytic episodes (not during). During hemolysis, deficient cells destroyed first → false negative.

⚠️ EXAM TIP: G-6-PD testing should be done BETWEEN hemolytic episodes, NOT during. During acute hemolysis, the most deficient cells are preferentially destroyed — leaving cells with relatively higher G-6-PD activity → falsely NORMAL result.

11.3 Cholinesterase (CHE) — Pseudocholinesterase

Feature	Details
Two types	True cholinesterase (AChE) = RBCs, nerve endings, brain. Pseudocholinesterase (BuChE) = liver, pancreas, serum.
Liver function	CHE synthesized by liver. Decreased CHE = impaired synthetic capacity. Reflects SYNTHETIC function.
Organophosphate poisoning	Insecticides (parathion, sarin) IRREVERSIBLY inhibit CHE. 40% drop → first symptoms. Treat with pyridine-2-aldoxime.
Succinylcholine sensitivity	Genetic CHE variants → succinylcholine persists → prolonged paralysis and APNEA. Life-threatening.
Dibucaine Number (DN)	Normal: DN ≥77. Atypical: DN <35. Heterozygous: DN ~60. Low DN = atypical = high succinylcholine risk.

⚠️ EXAM TIP — Dibucaine Number: Normal: Dibucaine STRONGLY inhibits CHE (>77% inhibition). Atypical: Only 20% inhibition. The LOWER the DN, the MORE ATYPICAL the enzyme, and the HIGHER the risk of succinylcholine apnea.

11.4 Macroenzymes

Feature	Details
Definition	High-MW enzyme complexes formed when serum enzymes bind to immunoglobulins (Type 1) or non-Ig substances (Type 2: oligomeric CK-Mt).
Clinical presentation	Asymptomatic patient with PERSISTENTLY ELEVATED enzyme. All organ tests NORMAL.
Macro-CK Type 1	CK-BB + IgG. Migrates between CK-MM and CK-MB. Most common in women >50. Falsely measured as CK-MB → false AMI.
Macro-CK Type 2	Oligomeric mitochondrial CK-Mt. Severe illness, malignancy. POOR PROGNOSIS.
Macro-AMY	AMY + IgG/IgA. Serum AMY elevated, urine AMY LOW. Asymptomatic. 1% population.
Detection	Electrophoresis (atypical bands). PEG 6000 precipitation: residual <30% = confirmed.

12. Mind Maps — Visual Summaries

MIND MAP 1: Enzyme Release — From Cell to Blood

TRIGGER: Any injury → ATP ↓ → membrane pump fails
Step 1: Na⁺ + water enter cell → SWELLING (reversible if stopped here)
Step 2: Ca²⁺ enters → activates phospholipases → membrane attack from inside
Step 3: Membrane leaks → CYTOPLASMIC enzymes leak first (EARLY MARKER)
Step 4: If irreversible → MITOCHONDRIAL enzymes also released (NECROSIS MARKER)
Route to blood: Liver = direct (capillaries). Muscle = indirect (lymphatics) = SLOWER

MIND MAP 2: CK Isoenzymes — Quick Pattern Recognition

CK-MM (CK-3) — Slowest migration (most cathodal)
94-100% of normal serum CK. Duchenne MD = 50-100× ULN (highest!)
CK-MB (CK-2) — Intermediate migration
Best enzymatic AMI marker. >6% = significant. Rise 4-8h / Peak 12-24h / Normal 48-72h
CK-BB (CK-1) — Fastest migration (most anodal)
Brain injury, smooth muscle tumors. Short half-life (1-5h).
Macro-CK Type 1 → migrates BETWEEN MM and MB → FALSE ↑ CK-MB
CK-Mt → cathodal to CK-MM → severe illness → POOR PROGNOSIS

MIND MAP 3: Liver Enzyme Pattern Interpretation

HEPATOCELLULAR DAMAGE PATTERN:
ALT + AST markedly elevated. ALP/GGT mildly elevated.
ALT > AST → viral hepatitis, NAFLD, toxic hepatitis
AST > ALT (ratio >2) → ALCOHOLIC HEPATITIS. Ratio >1 chronic → CIRRHOSIS.
CHOLESTATIC PATTERN:
ALP markedly elevated (3-10× ULN). GGT markedly elevated. ALT/AST mildly elevated.
KEY DIFFERENTIATOR: ALP↑ + GGT↑ = LIVER. ALP↑ + GGT NORMAL = BONE or PREGNANCY.

MIND MAP 4: Amylase vs Lipase — The Decision Framework

AMYLASE (AMY):
Rise 5-8h | Peak 24h | Duration 3-5 days (SHORT)
Low specificity (20-60%). Elevated in salivary disease.
LIPASE (LPS) ← PREFERRED:
Rise 4-8h | Peak 24h | Duration 7-14 DAYS (LONGER)
High specificity (80-100%). NOT elevated in salivary disease.
>3× ULN (no renal failure) = strong evidence for acute pancreatitis.

13. High-Yield ASCP Exam Facts — Quick Reference

The 25 Most Tested Points — Chapter 13: Enzymes

Cytoplasmic enzymes leak first = early/reversible injury. Mitochondrial enzymes = necrosis/irreversible.
Half-lives determine diagnostic windows. Short half-life = early marker. Long half-life = late marker.
Most enzymes cleared by reticuloendothelial system. NOT by kidney. Exception: Amylase (only enzyme in urine normally).
Zero-order kinetics REQUIRED for all enzyme activity assays — substrate must be in large excess.
Competitive inhibitor: Vmax unchanged, Km APPEARS increased. Can be overcome with more substrate.
Noncompetitive inhibitor: Vmax DECREASED, Km unchanged. Cannot overcome with more substrate.
Uncompetitive inhibitor: BOTH Vmax and Km APPEAR decreased. More substrate makes it WORSE.
Most common cause of non-linearity in enzyme assay = substrate depletion. Fix: dilute SAMPLE, not reagent.
NADH measured at 340 nm. NAD⁺ does NOT absorb at 340 nm.
CK elevated: Duchenne MD (50-100× ULN). Rhabdomyolysis (>200× ULN). Hypothyroidism. Exercise/IM injection.
CK-MB >6% of total CK OR mass >5 µg/L = significant. Rise 4-8h / Peak 12-24h / Normal 48-72h.
Macro-CK Type 1 (CK-BB + IgG): asymptomatic, women >50. Migrates between MM and MB.
LD STORAGE RULE: Room temperature ONLY. Refrigerator or freezer destroys LD-4 and LD-5.
Flipped LD pattern (LD-1 > LD-2) = AMI or intravascular hemolysis. Normal = LD-2 > LD-1.
LD stays elevated 10 DAYS after AMI — most useful for late presentation.
ALT = most liver-specific transaminase. AST is in more tissues (heart, muscle, RBCs).
AST:ALT >2 = ALCOHOLIC HEPATITIS. AST:ALT >1 in chronic liver disease = advanced fibrosis/cirrhosis.
ALP ↑ + GGT ↑ = LIVER source. ALP ↑ + GGT NORMAL = BONE or PREGNANCY.
Paget’s disease = HIGHEST ALP of any disease (10-25× ULN).
Placental ALP = MOST HEAT STABLE (65°C, 30 min). Regan isoenzyme also heat-stable.
LIPASE is the preferred first-line test for acute pancreatitis. Stays elevated 7-14 DAYS.
Amylase in pancreatitis: window only 3-5 days. Opiates ↑ AMY. Lipemia ↓ AMY falsely.
Macro-AMY: serum AMY elevated + urine AMY LOW + lipase NORMAL + asymptomatic.
G-6-PD testing: do BETWEEN hemolytic episodes (during = false negative). Test on RED CELL HEMOLYSATE.
Dibucaine Number: Normal ≥77%. Atypical <35%. Low DN = atypical = succinylcholine apnea risk.

🎯 Good luck on your ASCP exam!
Methods + Clinical Interpretation + Pre-analytical = the 3 pillars of ASCP success.

📝 Practice Quiz — Test Your Knowledge

Click an answer for each question. You’ll get instant feedback with a detailed explanation. Your final score appears at the end. Good luck!

0 of 10 answered

Question 1 of 10

A serum specimen from a patient with suspected acute pancreatitis has visibly cloudy plasma (severe lipemia). The serum amylase result returns as 68 U/L (reference range 28-100 U/L). The patient is symptomatic with abdominal pain. What is the most likely explanation for the normal amylase?

Question 2 of 10

A blood sample is drawn from a hospitalized patient for a CK and LD panel. The serum is mildly hemolyzed (pink-tinged). Which of the following best describes the expected effect of this hemolysis?

Question 3 of 10

A patient is admitted 5 days after experiencing chest pain. CK-MB is within normal limits. The physician suspects a late AMI presentation. Which enzyme pattern would best support this diagnosis?

Question 4 of 10

A 52-year-old woman has a persistently elevated CK of 450 U/L over 3 months. She is asymptomatic. Troponin is normal. On CK isoenzyme electrophoresis, a dense band appears migrating BETWEEN the positions of CK-MM and CK-MB. What is the most likely explanation?

Question 5 of 10

A 45-year-old patient with known alcoholism presents with elevated liver enzymes. Results: AST 240 U/L, ALT 95 U/L, ALP 180 U/L, GGT 620 U/L. What pattern do these results suggest and what is the most likely diagnosis?

Question 6 of 10

A technician receives a LD isoenzyme specimen that was refrigerated overnight (4°C) before analysis. The total LD activity is within normal limits. The isoenzyme pattern shows markedly decreased LD-4 and LD-5 with relatively preserved LD-1 and LD-2. What is the most appropriate action?

Question 7 of 10

A patient has an elevated serum amylase of 320 U/L. Urine amylase is measured and found to be LOWER than expected (within normal limits). The patient is asymptomatic. Lipase is 42 U/L (reference <64 U/L). Which condition best explains these findings?

Question 8 of 10

A patient undergoing pre-operative screening has a serum cholinesterase activity of 2.1 U/L (reference range 33-76 U/L for females) and a dibucaine number of 22. She has no liver disease. What is the clinical significance of these findings?

Question 9 of 10

Alkaline phosphatase is 380 U/L (reference: 42-98 U/L for females). GGT is 34 U/L (reference: 5-38 U/L). ALT is 28 U/L. AST is 25 U/L (normal). The patient is 34 weeks pregnant. What is the most likely source of the elevated ALP?

Question 10 of 10

A 28-year-old male presents with myalgia and dark urine after a vigorous workout. CK is 45,000 U/L (reference: 46-171 U/L). The CK-MB fraction is 8% of total. Troponin I is undetectable. Urine dipstick is positive for ‘blood’ but microscopy shows NO red blood cells. What is the diagnosis and how do you interpret the CK-MB?

🎉 Quiz Complete!

0/10

🎴 Flashcards — Active Recall Practice

Click the card to flip and reveal the answer. Mark each card as Knew it ✓ or Review again ✗ to track your progress. Click 🔀 Shuffle to randomize the deck. Your final summary appears when you finish or reach the last card.

Card 1 of 87✓ Knew: 0✗ Missed: 0

Question

Answer

Click card to reveal answer

🎴 Flashcard Session Complete!

0✓ Knew

0✗ Missed

0Unmarked

0% Recall